NCT06354764 Propensity to Hospitalize Patients From the ED in European Centers.
| NCT ID | NCT06354764 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Mario Negri Institute for Pharmacological Research |
| Condition | Emergency Medicine |
| Study Type | OBSERVATIONAL |
| Enrollment | 162,000 participants |
| Start Date | 2025-09-22 |
| Primary Completion | 2026-06 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 162,000 participants in total. It began in 2025-09-22 with a primary completion date of 2026-06.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The peer-to-peer comparison means center-to-center comparison, which requires adjusting for possible differences among centers to be fair and convincing. The first step to reach this goal is to develop a predictive model that accurately estimates each patient's probability of being admitted, starting from clinical conditions and boundary variables. Such a model would make it possible to calculate, for each ED, the expected hospitalization rate; that is, the hospitalization rate that would have been observed if the ED had behaved like the average of the EDs that provided the data to build the model itself. Comparing the observed hospitalization rate in the single ED with the expected rate derived from the model provides a rigorous method of comparing the department with the average performance, taking into account the characteristics of the patients treated and the conditions under which the ED operated. In other words, the predictive model represents the benchmark against which each ED is evaluated.
Eligibility Criteria
Inclusion Criteria: * Adult * Arrived at emergency department between 1 January 2021 and 31 December 2023 Exclusion Criteria: * None
Contact & Investigator
Guido Bertolini, MD
PRINCIPAL INVESTIGATOR
Istituto Di Ricerche Farmacologiche Mario Negri
Frequently Asked Questions
Who can join the NCT06354764 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Emergency Medicine. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06354764 currently recruiting?
Yes, NCT06354764 is actively recruiting participants. Contact the research team at chiara.pandolfini@marionegri.it for enrollment information.
Where is the NCT06354764 trial being conducted?
This trial is being conducted at Torino, Italy, Vercelli, Italy.
Who is sponsoring the NCT06354764 clinical trial?
NCT06354764 is sponsored by Mario Negri Institute for Pharmacological Research. The principal investigator is Guido Bertolini, MD at Istituto Di Ricerche Farmacologiche Mario Negri. The trial plans to enroll 162,000 participants.